2012 © Institute for Molecular Medicine Finland FIMM
Nordic EMBL Partnership
FIMM is characterized first and foremost by its partnership with the flagship of European biosciences research, the European Molecular Biology Laboratory (EMBL). The Nordic EMBL Partnership for Molecular Medicine was established on 3 October 2007, and it involves sister institutions in Umeå in Sweden and Oslo in Norway, each acting in their own areas of research. EMBL provides an organizational and administrative model, advice and a strong brand name for the launch and operation of FIMM. FIMM recruits promising principal investigators and PhD students globally according to the EMBL model. An important aspect for the future of EMBL collaboration is scientific and technological interaction. FIMM represents an important step for EMBL towards translational and medical research, and it is in the interest of both parties that links to medical research and biotechnology industry are enforced in Finland and in the EU.
Nordic EMBL Nordic Partnership for Molecular Medicine is based on the proven research strengths in Finland, which have created an initial focus for FIMM on three areas
- human genomics
- medical systems biology
- translational research
While all parties of the Nordic EMBL Partnership strive towards translational aims, FIMM is unique in its focus towards human genomics and medical systems biology.